Related Experiment Video
Updated: Jul 19, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Malignant non-Hodgkin's lymphoma developing late after pneumonectomy
Gregory Riehl1, Axel Aubert, Cristian Sandu
1Department of Thoracic and Vascular Surgery, A. Michallon Teaching Hospital, BP 217, 38043 Grenoble cedex 9, France. GRiehl@chu-grenoble.fr
Summary
A rare thoracic malignancy, malignant non-Hodgkin's lymphoma (MNHL), developed in a patient six years after treatment for benign bronchial stenosis. The patient achieved remission after chemotherapy and radiation therapy.
Area of Science:
- Thoracic oncology
- Hematologic malignancies
- Medical case reports
Background:
- A 64-year-old male underwent left pneumonectomy for benign bronchial stenosis in 1968.
- Long-term follow-up after thoracic surgery is crucial for detecting secondary conditions.
Observation:
- In 1997, a left parietal thoracic tumor was diagnosed as T-type malignant non-Hodgkin's lymphoma (MNHL).
- This rare presentation occurred 29 years post-pneumonectomy.
Findings:
- The MNHL was successfully treated with chemotherapy and radiation therapy.
- The patient remained alive and in remission six years after treatment.
- Only one prior case of MNHL in this specific location was found in the literature.
Implications:
- This case may represent a rare instance of pyothorax-associated lymphoma (PAL).
- Further research into PAL, particularly from non-Japanese literature, is warranted.
- Highlights the importance of vigilance for secondary malignancies after extensive thoracic procedures.
Related Concept Videos
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations: